Jury finds punitive damages warranted against Boehringer Ingelheim Pharmaceuticals, Inc.
Support for 'In-Between Visit' Care Management for People with Behavioral Health Diagnoses, Developmental Disabilities and Drug Addiction
Anonymous donor presents $1 million gift to The Ehlers-Danlos Society to jumpstart groundbreaking genomic research into genetic cause of hypermobile Ehlers-Danlos syndrome (hEDS), a rare, degenerative, and all-too-often painful, disabling connective tissue disorder
New service for seniors will be led by Dr. Anna Monias.
Rapidly Growing Patient Populations and New Drug Classes are Key Drivers in this Market According to Greystone Research Associates
Proliferation of Lyophilized Drugs Creating Demand for Patient-Friendly Reconstitution According to Greystone Research Associates
Developers Turning to New Materials and Advanced Electronics According to Greystone Research Associates
Growing Emphasis on Adherence and Adaptive Learning are Key Drivers in this Market According to Greystone Research Associates
Program highlighted in new issue of Better Tennessee magazine
World experts in Portland share the latest Trials and Studies for Cancer at the LDN 2017 Conference.
The Story Behind The (re)brand.
Tailored Therapy Provides Relief to Thousands Living In Texas
Recognizing May as Better Hearing and Speech Month
Leading a 10 Day, 233 Mile Journey by Wheelchair from Yankee Stadium to Washington DC, Determined To Strike Out ALS, May 5-15, 2017
Recognizing April as National Parkinson's Awareness Month
Powerful Cell Guidance Systems' technology is being applied to the treatment of a disease that causes chronic pain for millions of people.
This event is shaping up to overshadow the 2016 event with more prominent speakers added, a larger expo and much higher attendance.
After bringing together 25 of the world's top medical and scientific minds to discuss how nutrition can treat and prevent serious disease at the largest-ever low-carb conference in San Diego, Low Carb USA has achieved its aim of creating a stir and initiating momentum toward change in the perceptions of what we should eat and the government guidelines that shape those perceptions.
Why do doctors still prescribe insulin for type 2 diabetes when compelling re-search proves that to do so is virtually useless? Canadian nephrologist Dr. Jason Fung will address this and the role of insulin in Obesity at Low Carb USA - San Diego 2016 conference later this month. He will focus on the science of therapeutic fasting and its undeniable success as a tool in treating both type 2 diabetes and obesity.
Saturated fat won't clog your arteries. It won't give you a heart attack or stroke. Denver's Diet Doctor, Dr. Jeffry Gerber, and the man known as The Fat Emperor, Ivor Cummins, will dispel these and other dangerous myths about heart disease at Low Carb USA - San Diego 2016 in July.
The world's leading doctors and scientists will present the latest evidence at the Low Carb USA conference in San Diego in July to show, amongst other things, that obesity is not from gluttony and sloth. They will explain why the so-called CICO model of calories in, calories out is unscientific and just plain wrong. The experts will also look at the role of hormones, driven by excessive sugar and carbohydrates in the diet, that play a significant role in obesity and other serious health issues.